期刊
FRONTIERS IN IMMUNOLOGY
卷 12, 期 -, 页码 -出版社
FRONTIERS MEDIA SA
DOI: 10.3389/fimmu.2021.635767
关键词
type 1 diabetes (T1D); immunotherapy; autoimmune disease (AD); T cells; Tregs (regulatory T cells); nanotechnology; nanomaterials; antigen-specific therapies; cell-based therapeutics
类别
资金
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [1R01 DK-102911]
Despite decades of research, translating autoimmune mechanisms underlying Type 1 Diabetes into effective therapeutics remains challenging. Restoring Treg functions to target specific autoantigens or localize in the pancreas is a sought-after strategy for treating the disease. Developing precise Treg therapies beyond broad activation is promising, with a focus on ex vivo generation and in situ stimulation of optimized Tregs.
Despite many decades of investigation uncovering the autoimmune mechanisms underlying Type 1 Diabetes (T1D), translating these findings into effective therapeutics has proven extremely challenging. T1D is caused by autoreactive T cells that become inappropriately activated and kill the beta cells in the pancreas, resulting in insulin insufficiency and hyperglycemia. A large body of evidence supports the idea that the unchecked activation and expansion of autoreactive T cells in T1D is due to defects in immunosuppressive regulatory T cells (Tregs) that are critical for maintaining peripheral tolerance to islet autoantigens. Hence, repairing these Treg deficiencies is a much sought-after strategy to treat the disease. To accomplish this goal in the most precise, effective and safest way possible, restored Treg functions will need to be targeted towards suppressing the autoantigen-specific immune responses only and/or be localized in the pancreas. Here we review the most recent developments in designing Treg therapies that go beyond broad activation or expansion of non-specific polyclonal Treg populations. We focus on two cutting-edge strategies namely ex vivo generation of optimized Tregs for re-introduction in T1D patients vs direct in situ stimulation and restoration of endogenous Treg function.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据